2-((5-Chloropyridin-3-yl)oxy)-3-nitropyridine

Catalog No. :
ACMWOE445
CAS No. :
175135-51-0
Molecular Formula :
C10H6ClN3O3
Molecular Weight :
251.63

IUPAC Name:2-((5-chloropyridin-3-yl)oxy)-3-nitropyridine

2-((5-Chloropyridin-3-yl)oxy)-3-nitropyridine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g95%$97.00Login to see priceInquiryInquiry
5g95%$292.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-((5-Chloropyridin-3-yl)oxy)-3-nitropyridine
IUPAC Name2-((5-chloropyridin-3-yl)oxy)-3-nitropyridine
MDL No.MFCD00067786
Molecular FormulaC10H6ClN3O3
Molecular Weight251.63
SMILESO=[N+](C1=CC=CN=C1OC2=CC(Cl)=CN=C2)[O-]
InChI KeyLXOSOXNFZKOICS-UHFFFAOYSA-N
Synonym2-[(5-CHLORO-3-PYRIDYL)OXY]-3-NITROPYRIDINE;BUTTPARK 97\12-44;3-CHLORO-5-(3-NITROPYRIDIN-2-YLOXY)PYRIDINE;2-((5-Chloropyridin-3-yl)oxy)-3-nitropyridine;Pyridine, 2-[(5-chloro-3-pyridinyl)oxy]-3-nitro-
CAS No.175135-51-0

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACMWOE445 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACBXKI483 route compound structure diagram
    ACBXKI4835470-18-8 In Stock
  2. Plus
  3. ACGPLJ764 route compound structure diagram
    ACGPLJ76474115-12-1 In Stock
  4. Then
  5. ACMWOE445 route product structure diagram
    ACMWOE445175135-51-0
Inquiry

2. ACMWOE445 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACPBYK143 route compound structure diagram
    ACPBYK14319755-53-4 In Stock
  2. Plus
  3. ACGPLJ764 route compound structure diagram
    ACGPLJ76474115-12-1 In Stock
  4. Then
  5. ACMWOE445 route product structure diagram
    ACMWOE445175135-51-0
Inquiry

Comments (0)